Wednesday 8 August 2018

CAPLIN POINT Plunges by 5%; BSE HEALTHCARE Index Down 0.1%

CAPLIN POINT share price has plunged 5% and is presently trading at Rs 399.
Meanwhile, the BSE HEALTHCARE Index is at 14,602 (down 0.1%).
Among the top losers in the BSE HEALTHCARE Index today is CAPLIN POINT (down 5.2%).
FDC LTD. (up 2.5%) and GSK PHARMA (up 1.9%) are among the top gainers today.
Over the last one year, CAPLIN POINT has moved down from Rs 758 to Rs 399, registering a loss of Rs 359 (down 47.4%)..
The BSE HEALTHCARE has moved up from 13,891 to 14,602, registering a gain of 711 points (up 5.1%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 81.8%), IPCA LABS (up 69.9%) and DIVIS LABORATORIES (up 68.2%).

What About the Benchmark Indices?

The BSE Sensex is at 37,776 (up 0.1%). The top gainers among the BSE Sensex stocks today are ASIAN PAINTS (up 1.6%), RELIANCE IND. (up 0.9%) and SBI (up 0.8%). Other gainers include ONGC (up 0.8%) and YES BANK (up 0.6%). The most traded stocks in the BSE Sensex are ITC LTD and TATA STEEL.
In the meantime, NSE Nifty is at 11,423 . BANK OF BARODA (up 2.2%) is among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 32,274 to 37,776, registering a gain of 5,502 points (up 16.8%).

CAPLIN POINT Financial Update...

CAPLIN POINT net profit stood at Rs 111 million for the quarter ended March 2015, compared to a profit of Rs 105 million a year ago. Net Sales rose 4.5% to Rs 636.0 million during the period as against Rs 609.0 million in January-March 2014.
For the year ended June 2011, CAPLIN POINT reported 90.9% increase in net profit to Rs 63.0 million compared to net profit of Rs 33.0 million during FY10.
Revenue of the company grew 34.1% to Rs 779 million during FY11.
The current Price to earnings ratio of CAPLIN POINT, based on rolling 12 month earnings, stands at 15.7x.
This article was originally published in English at www.equitymaster.com
Read the complete Indian stock market update. For the terms of use, go here.

No comments:

Post a Comment